Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
about
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionEthical aspects of malaria control and researchGametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient dataTransmission-blocking strategies: the roadmap from laboratory bench to the communityNew developments in anti-malarial target candidate and product profilesSingle Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient SubjectsAge, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionGlucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.Malaria: an update on current chemotherapy.Primaquine: the risks and the benefitsOperational research on malaria control and elimination: a review of projects published between 2008 and 2013.Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaHistone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humansThe gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trialMass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care testsGametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparumModelling the therapeutic dose range of single low dose primaquine to reduce malaria transmission through age-based dosing.High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission.Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in UgandaSafety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in TanzaniaAdding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.Key Knowledge Gaps for Plasmodium vivax Control and EliminationThe Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.New insight-guided approaches to detect, cure, prevent and eliminate malaria.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.Determinants of Malaria Transmission at the Population Level.Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
P2860
Q24188070-38168653-5657-4F35-8568-3275D36F2E80Q24193716-A8DBD94D-D6EC-4397-89F2-8F811B25E77DQ26773470-B47CF078-3B04-4994-9250-73948674971AQ28068072-9D8A7301-A1D3-4AA9-9A3F-FF5764D56058Q28078982-2485BED5-D379-4822-9480-E559FF6A9D19Q28468598-32539ACE-BA47-4108-9B45-76C219786A56Q28550990-BC5A29D9-6896-4821-89D1-22F7A2315C66Q33601837-352643D1-763E-423B-945F-F8C661276FACQ33772980-C9C7FA68-4F49-4772-BC6B-0239F01A7F08Q33901814-812CB97F-4EF7-47A7-80C3-6B47D5F62FC7Q34020818-6BACD956-CF96-44D3-97B7-FE73219F08ACQ34058341-AE5B62DE-5B13-41E6-8ECC-043392068C72Q34433106-2A18F040-1AA3-4155-BCAA-6FBADD42235EQ34503631-146EBB65-3A7E-4E7D-B705-6435B952F614Q34695192-90182BF3-398E-4461-AAD7-421F8B1EFBFDQ34922792-74D6A6DF-E06B-47D1-B539-A6517EA16275Q34968407-02728E3A-FE1A-4A87-9123-CB437F29F5AFQ35105899-27D6934B-0CA6-4910-938D-13047EF6CDD1Q35147721-E21E381C-38AC-41E6-996C-B1499F0B5A30Q35224221-B5CCF151-AFB5-45A7-A5D6-DDE0E4F09A75Q35272795-6E115239-C9A3-4483-8BA9-BF93BAD0B274Q35860086-33FD63EB-FF04-4C04-91FE-24D7395E81E2Q35948587-759B0530-FB93-41D8-BF7B-210EF54FF38CQ36290632-58DB4634-E2C1-422E-8AFE-74DCA0A36B8DQ36340896-FA41B6FC-4C61-4930-94F9-5B922CDE897BQ36492518-3F51BE34-C85D-4AEE-A083-E4C21153247DQ36667896-A1E0C90F-61A0-450B-9B52-8330DC27CA2BQ36919292-D971D6C5-220B-4DFD-AFE7-410C3364E420Q36991071-A6F23303-B29C-4711-A702-71D3FDEC8FFEQ37211878-37A8A844-5540-45A1-B797-B9ECF0B520C4Q37287860-87A499D4-A89E-4DE1-9F40-5BBE6D258CEBQ37546198-B7BBDB76-80EA-4876-A76A-3F08FB343FEFQ37604926-8E8B18D1-6039-4866-A895-0D929F8BD001Q37737972-E37D2D05-A38B-4828-A00A-462FD7A5AC8BQ38260909-ECBC22B8-A061-45C0-8F87-6E58E2357B0DQ38529669-04EBD0D7-2AE9-4696-9A96-EC02CC736645Q38613700-1DDABE4C-9180-4BE3-A10C-26F1052F504FQ38917744-2237D1D0-FE3E-4EFB-A667-173D8245BAA3Q39331198-A161BEE2-9282-4BB8-8CFC-BDD0CF3E1970Q39525461-2D41E40B-7CFD-4A91-B997-E0F48CF19ADB
P2860
Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@ast
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@en
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@nl
type
label
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@ast
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@en
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@nl
prefLabel
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@ast
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@en
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@nl
P2093
P50
P921
P1476
Single dose primaquine for cle ...... ble-blind, dose-ranging trial.
@en
P2093
Alice C Eziefula
Arthur Mpimbaza
Asiphas Owaraganise
Grace Gabagaya
Humphrey Wanzira
John Bradley
Kjerstin H W Lanke
Lynn Grignard
Samuel Nsobya
Shunmay Yeung
P304
P356
10.1016/S1473-3099(13)70268-8
P577
2013-11-13T00:00:00Z